Stock Watch:

Brompton Funds specializes in split share corporations, delivering steady income and growth potential for investors through its expertly managed portfolios.
Explore the Blockchain Technologies ETF, offering exposure to the growing world of fintech, crypto mining, and blockchain advancements.
Bonterra Resources is strengthening its position in the Abitibi gold region through a strategic partnership and key assets, focusing on growth and exploration in this rich mining territory.
HomeBTV ShowBTV FeaturesCEO ClipsArticlesInvestor AlertsTV Ad SpotsAnalysts & ExpertsThe Agency
Request Investor Info

FOX - Diagnos: A Leader in Artificial Intelligence & Healthcare Technical Services Since 2001

Healthcare
December 15, 2021

An AI company

Diagnos is a publicly-traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and development of applications such as CARA (Computer Assisted Retina Analysis). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

For more information on Diagnos Inc. (TSX.V: ADK) please click the request investor info button.

how to buy stocks
Investing
investing for beginners
new stocks to buy
stock market
stock picks
stocks
stocks to buy

Latest Articles

TD Q U.S. Small-Mid-Cap Equity ETF Offers an Investment Opportunity Not Seen in a Long TimeETFs
Centurion CEO Romundt Sees Generational Opportunity in Real EstateFinance
How TDAM is Redefining Technology InvestingFinance
The Canadian Securities Exchange - 20 Years a DisruptorFinance

Hot Companies

STLLR Gold
Aston Bay Holdings
KITS Eyecare Ltd.

You might also like

Healthcare
Medicus Pharma: Treatment with Non-Invasive Solutions

Medicus Pharma is transforming skin cancer care with its innovative, non-invasive chemotherapy delivery system, providing a safer and more effective alternative to traditional surgery.

Healthcare
Lexaria Bioscience: Revolutionizing GLP-1 Drug Delivery with Patented Oral Platform

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, The Globe and Mail, YouTube and more!

Discover Investment Opportunities!

Corp. Videos
Advertising
Broadcast Schedule
The Crew
About us
Contact